Xiaojiang Tang

Statistics

Publications

Citations

167

H-Index

Active since

2015

Affiliations

First Affiliated Hospital of Xi'an Jiaotong University(Current)

Xiaojiang Tang is an author at First Affiliated Hospital of Xi'an Jiaotong University specializing in microrna biology, molecular oncology, and microrna in cancer.

ORCID

Publications per year

2015–2024

Publications

Sinomenine hydrochloride inhibits the progression of plasma cell mastitis by regulating IL-6/JAK2/STAT3 pathway

Yang Liu, Yushi Sun, Yuhui Zhou et al. · International Immunopharmacology · 2019 · 38 citations

Veterinary Medicine, Immunology, Pharmacotherapy +12

IL-6/STAT3 signaling pathway is activated in plasma cell mastitis.

Yang Liu, Jian Zhang, Yuhui Zhou et al. · PubMed · 2015 · 35 citations

Life Sciences, Immunology, Pathology +17

MicroRNA-1297 contributes to tumor growth of human breast cancer by targeting PTEN/PI3K/AKT signaling

Chao Liu, Zhikui Liu, Xiao Li et al. · Oncology Reports · 2017 · 34 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

miR‑139‑3p suppresses the invasion and migration properties of breast cancer cells by targeting RAB1A

Wei Zhang, Jing Xu, Ke Wang et al. · Oncology Reports · 2019 · 26 citations · Full text

Medicine, Bioinformatics, Oncology +15

<p><em>LINC00461</em> Overexpression Can Induce Docetaxel Resistance in Breast Cancer by Interacting with miR-411-5p</p>

Cheng Zhang, Jizhao Wang, Jiawei Zhang et al. · OncoTargets and Therapy · 2020 · 21 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–5 of 6